Grants
| Collaborators | Funding | |
|---|---|---|
| PET4PETs We will build a new generation of multi-tracer PET to improve staging and allow screening for personalized target based cancer therapy in dogs and humans affected by sarcoma. |
Institut für Teilchenphysik ETH / Radiopharmazie des Paul Scherrer Institut Kantonsspital Baden /Universitätsspital Zürich / Kantonsspital Baden | SNF 2025-2029 |
| Personalizing hypo- and ultra-hypofractionated radiotherapy We leverage spontaneous canine tumors to develop an RNAseq-derived fraction-dynamic radiosentitivity signature |
Medizinphysik (Radiotherapie Hirslanden, Physik UZH) / Applied Complex Systems Scientists der ZHAW | SNF 2025-2029 |
| Deciphering the STS-landscape We combine spatially defined transcriptomics with clinical outcome data to improve diagnosis and therapy of canine soft-tissue sarcoma |
American Kennel Club | |
|
FEATHER-trial (phase II/III randomized trial)
|
Paul Scherrer Institut / Oncology Department, HUG | Swiss Cancer Research 2023-2026 |
|
vISION-S (Phase III randomized trial) |
Institute for Veterinary Pathology Vetsuisse Zürich (Frauke und Paula verlinken), MEEI Institute Harvard University |
SNF 2025-2028 Gesellschaft für Kynologische Forschung (2023-2026) |
| DECODE-AS (ex-vivo) We sequence hemangiosarcoma to detect new diagnostic and therapeutic targets. |
Institute for Veterinary Pathology Vetsuisse Zürich | Morris Foundation D24CA-044 (2024-2026) |
| Charakterisierung von Tumor spezifischen Proteinsignaturen zur Ziel-gerichteten Tumortherapie beim soliden und disseminierten Histiozytären Sarkom. We sequence histiocytic sarcoma to detect new diagnostic and therapeutic targets. |
Institute for Veterinary Pathology Vetsuisse Zürich | Albert-Heim Stiftung (2023-2026), American Kennel Club (2024-2027) |
|
Vergleichende Untersuchung von Indocyanin Grün und AngiostampTM zur Verbesserung der chirurgischen Therapie bei Hunden mit peripheren Nervenscheidentumoren des Plexus Brachialis oder Lumbalis. 10.17590/asr.0000320 |
Institute for Veterinary Pathology Vetsuisse Zürich | Gesellschaft zur Förderung kynologischer Forschung |
| STS across species We leverage similarity in STS between humans and dogs to identify novel treatments for patients of both species. |
Charité Berlin, Institute for Veterinary Pathology Vetsuisse Zürich | SNF 2025-2028 |
| USTS in dogs We identify novel tumor-specific targets in canine undifferentiated soft-tissue sarcomas for novel therapies. |
Institute for Veterinary Pathology Vetsuisse Zürich | Gesellschaft zur Förderung kynologischer Forschung |
| Decipher-STS dog We study the single-cell landscape of soft-tissue sarcomas in dogs to identify novel therapy targets. |
Morris Animal Foundation (D24CA-046) | |
| Decipher-STS cat We study the single-cell landscape of soft-tissue sarcomas in cats to identify novel therapy targets. |
EveryCat Health Foundation |